Results 161 to 170 of about 1,044,683 (223)

Analysis of the chemotherapy effect of albumin-bound paclitaxel combined with pirarubicin and cyclophosphamide on breast cancer and the effects of PCR, ORR, and CBR. [PDF]

Pak J Med Sci
Liu Y, Gong K, Yuan S, Xu Y.
europepmc   +1 more source

Factors affecting peripheral neuropathy induced by nanoparticle albumin-bound paclitaxel in patients with pancreatic cancer. [PDF]

Br J Clin Pharmacol
Kang M, Yoo S, Jung Y, Lim H, Lee MH, Ryu JK, Lee JI.   +6 more
europepmc   +1 more source

Combination of anlotinib and albumin-bound paclitaxel in 2^nd line and above treatment of advanced gastric cancer: A retrospective study. [PDF]

World J Clin Oncol
Liu WM, Liu YR, Peng Y, Tang J, Li XB.
europepmc   +1 more source

Neoadjuvant chemotherapy with albumin-bound paclitaxel plus cisplatin and capecitabine for locally advanced esophageal squamous cell carcinoma: a phase 2 clinical trial. [PDF]

Int J Surg
Zhang W, Chen X, Xue L, Jiang Z, Qu D, Yang Z, Qin J, Wang Z, Zhang M, Li Y, Zhou A, Gao S.   +11 more
europepmc   +1 more source

Suppression of the LKB1-AMPK-SLC7A11-GSH signaling pathway sensitizes NSCLC to albumin-bound paclitaxel via oxidative stress. [PDF]

Redox Biol
Rong D, Gao L, Chen Y, Gao XZ, Tang M, Tang H, Gao Y, Lu G, Ling ZQ, Shen HM.   +9 more
europepmc   +1 more source

Efficacy and safety of nanoparticle albumin‑bound paclitaxel compared with solvent‑based paclitaxel in adjuvant therapy for breast cancer: A retrospective study. [PDF]

Oncol Lett
Lv H, Hong Y, Zhang Y, Li S, Li B, Zhang M.   +5 more
europepmc   +1 more source

Efficacy and safety of nanoparticle albumin-bound paclitaxel plus cisplatin or nedaplatin plus tegafur/gimeracil/oteracil as induction chemotherapy regimen for hypopharyngeal cancer. [PDF]

Front Oncol
Jiang C, Liu Y, Mo Y, Xu L, Zhu L, Li Z, Xu S, Qin X, Wu G, Kang M, He X, Xue F.   +11 more
europepmc   +1 more source

Neoadjuvant with low-dose radiotherapy, tislelizumab, albumin-bound paclitaxel, and cisplatin for resectable locally advanced head and neck squamous cell carcinoma: phase II single-arm trial. [PDF]

Nat Commun
Liu Z, Wang D, Li G, Yi M, Zhang Z, Zhong G, Xu L, Jiang R, Zheng Y, Huang L, Peng Y, Liang L, Li J, Liu Y, Lai J, Lv X, Xu Y, Liu Q, Wang Z, Liu Z, Yang Q, Nie L, Lei J, Huang X, Liu Z, Jiang W.   +25 more
europepmc   +1 more source

Hemorrhagic cystitis in gastric cancer after nanoparticle albumin-bound paclitaxel: A case report. [PDF]

World J Gastrointest Oncol
Zhang XJ, Lou J.
europepmc   +1 more source

Risk comparison of adverse reactions between gemcitabine monotherapy and gemcitabine combined with albumin-bound paclitaxel in pancreatic cancer: insights from the FDA Adverse Event Reporting System (FAERS) database. [PDF]

BMC Pharmacol Toxicol
Jiang P, Zong K, Peng D, Zhou B, Wu Z.
europepmc   +1 more source